babutaaniket

SAMRATPH - Analysis

babutaaniket 업데이트됨   
BSE:SAMRATPH   SAMRAT PHARMACHEM LTD.
Samrat Pharmachem Limited is engaged in the production of pharmaceutical chemicals like Iodine salts and Bromine salts. The Company's finished products are used in various industries, including pharmaceuticals, chemicals, food, fertilizer and salt.

Financials:
TTM EPS: 53.83
TTM PE: 7.25
P/B; 1.91
Face Value: 10
Mkt Cap (Rs. Cr.): 120
Dividend Yield: 0.26
Sector PE: 43.66
Book Value Per Share: 204.37

Positives:
  1. Company with Low Debt
  2. Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  3. Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
  4. Book Value per share Improving for last 2 years
  5. Company with Zero Promoter Pledge

Negatives:
  1. Decline in Net Profit with falling Profit Margin (QoQ)
  2. Decline in Quarterly Net Profit with falling Profit Margin (YoY)
  3. Declining profits every quarter for the past 3 quarters
  4. Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
  5. Weak Momentum: Price below Short, Medium and Long Term Averages

Opinion: It has TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE. Can it reverse from this support zone ?

NOT A RECOMMENDATION. JUST FOR EDUCATION. Thanks.
액티브 트레이드:
CMP 405.
액티브 트레이드:
CMP 430

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.